Hemera Board of Directors: Updates to Its Composition
For personal reasons, Aldo Cocchiglia will step down from the Board of Directors effective May 3, 2023. Two years after Hemera’s founding, the shareholders express their gratitude to Mr. Cocchiglia for his commitment and contribution to the company’s development, along with their best wishes for his future endeavors.
The Shareholders’ Meeting also decided to confirm the current composition of the Board of Directors: Chairman Prof. Guido Fumagalli, CEO Dr. Cristiana Vignoli, Director of Research and Development Prof. Ilaria Decimo, and Director of Therapy Development Prof. Francesco Bifari. They will continue to pursue the company’s goals and mission with the same passion and dedication that have allowed Hemera to quickly achieve significant milestones over the past years.